Inactive Instrument

News Aura Health Inc Toronto S.E.

Equities

GIR

CA5134413031

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Pharmadrug's Securedose Announces LOI with Canadian Controlled Drug Substance Licensed Dealer for Patent Pending Pharmaceutical Grade Cocaine	05-23	NE
PharmaTher's Sairiyo Submits Clinical Trial Application in Australia For Phase 1 Study of Reformulated Cepharanthine	05-15	MT
PharmaDrug's Sairiyo Therapeutics Submits Clinical Trial Application for Phase 1 Study of Patented Reformulated Cepharanthine	05-15	NE
PharmaDrug Provides Forward Plan to Move Its Patent Pending Process and Formulation of Pharmaceutical Grade Biosynthetic Cocaine Through Development into Commercialization	05-13	NE
PharmaDrug Announces Directorate Changes	05-02	CI
PharmaDrug Announces Director Appointment and Resignation	05-02	NE
PharmaTher's Sairiyo Therapeutics Completes Regulatory Package For Phase 1 Study of Reformulated Cepharanthine in Australia	05-01	MT
PharmaDrug's Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine	05-01	NE
Pharmadrug Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-30	CI
PharmaDrug's SecureDose Announces the Advancement of Process Development of Its Biosynthetic Formulation of Pharmaceutical Grade Cocaine	04-16	NE
PharmaTher Updated on its Priority Original Abbreviated New Drug Application for Ketamine	04-16	MT
Pharmadrug's SecureDose Announces Filing of US Provisional Patent for Manufacturing Method for Biosynthetic Pharmaceutical Grade Cocaine	03-13	CI
PharmaDrug's SecureDose Announces Filing of US Provisional Patent for Manufacturing Method for Biosynthetic Pharmaceutical Grade Cocaine	03-13	NE
PharmaDrug Inc Announces Board Changes	02-27	CI
PharmaDrug Appoints Current Board Member Dr. David Kideckel as Chairman	02-27	NE
PharmaTher Provides Update For PD-001	02-21	MT
PharmaDrug's Sairiyo Successfully Demonstrates Ability to Manufacture Cepharanthine (PD-001) for Human Clinical Studies	02-14	NE
Pharmadrug Inc. Announces Marketing and Distribution Services Agreement with Outside the Box Capital Inc	02-12	CI
PharmaDrug Inc. Engages Investor Relations and Marketing Service Providers	02-12	NE
PharmaDrug Inc. Announces Successful Closing of Non-Brokered Private Placement	02-08	NE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Aura Health Inc Toronto S.E.

Equities

GIR

CA5134413031

Summary

Filters